Shire inches closer to Baxalta buy with cash-sweetened bid

Carly Helfand

 has offered up a new bid for elusive target  that's more or less what the Illinois drugmaker has been looking for, reports say. But that doesn't mean isn't exploring its other options.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS